tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Citi opens ‘upside 90-day short-term view’ on West Pharmaceutical

Citi keeps a Buy rating on West Pharmaceutical (WST) with a $300 price target while adding an “upside 90-day short-term view.” The firm views West as one of the stronger margin stories in the space, and sees potential room for upside to consensus earnings estimates this year “when the temporary headwinds are in the rearview.”

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1